The Effect of Exercise With Wearable Walking Assist Robot in Various Environments

February 27, 2023 updated by: Yun-Hee Kim, Samsung Medical Center

The Effect of Exercise With Wearable Walking Assist Robot in Various Environments in Healthy Adults

This single-blinded, randomized, controlled trial includes 60 healthy adults. The participants were randomized to four different groups. The first group performed over-ground walking without GEMS-H, the second group performed over-ground walking with GEMS-H applied resistance mode, the third group performed stair ascent with GEMS-H applied assist mode, and the fourth group were designated as the group that performed inclined gait with GEMS-H applied assist mode on a treadmill. Each group is divided in 15 participants.

Study Overview

Detailed Description

At the first visit, the subjects are fully informed of the study if appropriate after determining whether they meet the selection criteria. If the subjects meet the selection criteria, the participants were randomized to four different groups. The first group performed over-ground walking without GEMS-H, the second group performed over-ground walking with GEMS-H with resistance mode, the third group performed stair ascent with GEMS-H with assist mode, and the fourth group were designated as the group that performed inclined gait with GEMS-H with assist mode on a treadmill. Each group is divided in 15 participants. Each group completed 30 minutes exercise at least three times per week (total 10 sessions). All measurements were conducted before and after the intervention.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 84 years (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy adults aged 50 to less than 85 years without a history of central nervous system disease

Exclusion Criteria:

  • Those who have difficulty walking independently due to problems such as visual field defects or fractures
  • Those with severe arthritis or orthopedic problems limiting passive range of motion (ROM) of the lower extremities (knee flexion contracture >10°, knee flexion ROM <90°, hip flexion contracture >25°, ankle plantar flexion contracture >15°)
  • Those who have difficulty understanding the exercise program due to severe cognitive decline (Korean-Mini-Mental State Examination, K-MMSE≤10)
  • Those who have difficulty participating in exercise programs due to adult diseases such as uncontrolled hypertension and diabetes
  • Those who are at risk of falling while walking due to severe dizziness
  • Those who are less than 140 cm or more than 185 cm in height that is not suitable size for the wearing of the walking assistance robot
  • Those who are overweight based on body mass index (BMI) 35 or higher

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Over-ground walking without GEMS-H
Over-ground walking without GEMS-H (30 min per session, at least 3 times per weeks, total 10 sessions)
Experimental: Over-ground walking with GEMS-H with resist mode
Over-ground walking with GEMS-H with resist mode (30 min per session, at least 3 times per weeks, total 10 sessions)
Experimental: Stair ascent with GEMS-H with assist mode
Stair ascent with GEMS-H with assist mode (30 min per session, at least 3 times per weeks, total 10 sessions)
Experimental: Incline walking with GEMS-H with assist mode
Incline walking with GEMS-H with assist mode (30 min per session, at least 3 times per weeks, total 10 sessions)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline performance on gait speed after the intervention
Time Frame: Baseline, After the intervention(day12)
Measure of self selected speeds by measuring the time it takes an individual to walk 10 meters. To perform the test, patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: "Please walk this distance at your normal pace when I say go."
Baseline, After the intervention(day12)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline performance on muscle strength after the intervention
Time Frame: Baseline, After the intervention(day12)
All subjects underwent measurements of muscle strength of lower extremity by using Commander Echo Muscle Tester (measures in lb, kg, N)
Baseline, After the intervention(day12)
Change from baseline performance on Short Physical Performance Battery (SPPB) after the intervention
Time Frame: Baseline, After the intervention(day12)
The Short Physical Performance Battery (SPPB) is a series of tests used to evaluate lower extremity function and mobility.
Baseline, After the intervention(day12)
Change from baseline performance on Functional Reach Test (FRT) after the intervention
Time Frame: Baseline, After the intervention(day12)
Functional Reach Test (FRT) is a clinical outcome measure and assessment tool for ascertaining dynamic balance in one simple task.
Baseline, After the intervention(day12)
Change from baseline performance on Four Square Step Test (FSST) after the intervention
Time Frame: Baseline, After the intervention(day12)
Four Square Step Test (FSST) is a test of dynamic balance and coordination that clinically assesses the participant's ability to step over objects forward, sideways, and backwards.
Baseline, After the intervention(day12)
Change from baseline performance on Berg Balance Scale (BBS) after the intervention
Time Frame: Baseline, After the intervention(day12)
Berg Balance Scale (BBS) is a 14-item objective measure that assesses static balance and fall risk in adults.
Baseline, After the intervention(day12)
Change from baseline performance on Timed Up and Go test (TUG) after the intervention
Time Frame: Baseline, After the intervention(day12)
The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.
Baseline, After the intervention(day12)
Change from baseline performance on Geriatric Depression Scale (GDS) after the intervention
Time Frame: Baseline, After the intervention(day12)
The Geriatric Depression Scale (GDS) is a self-report measure of depression.
Baseline, After the intervention(day12)
Change from baseline performance on EuroQol 5 Dimensions (EQ-5D) after the intervention
Time Frame: Baseline, After the intervention(day12)
EQ-5D is an instrument which evaluates the generic quality of life developed in Europe and widely used. The EQ-5D descriptive system is a preference-based HRQL measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Baseline, After the intervention(day12)
Change from baseline performance on Fall Efficacy Scale-Korea (FES-K) after the intervention
Time Frame: Baseline, After the intervention(day12)
The Falls Efficacy Scale (FES) is a ten-item test rated on a 10-point scale from not confident at all to completely confident.
Baseline, After the intervention(day12)
Change from baseline performance on metabolic energy expenditure after the intervention
Time Frame: Baseline, After the intervention(day12)
All subjects underwent measurements respiratory metabolism energy during treadmill walking at a comfortable speed for 5 minutes. It assess the change of metabolic energy expenditure using a portable cardiopulmonary metabolic system (K5, Rome, Italy).
Baseline, After the intervention(day12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 7, 2021

Primary Completion (Actual)

September 30, 2021

Study Completion (Actual)

September 30, 2021

Study Registration Dates

First Submitted

June 1, 2021

First Submitted That Met QC Criteria

June 7, 2021

First Posted (Actual)

June 9, 2021

Study Record Updates

Last Update Posted (Actual)

March 1, 2023

Last Update Submitted That Met QC Criteria

February 27, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-03-052

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Over-ground walking without GEMS-H

Subscribe